KRAS抑制剂战火纷飞，大小公司各显神通
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies - ScienceDirect
加科思-B：将于2022年ESMO ASIA公布JAB-21822与JAB-3312联合用药临床前研究成果|界面新闻
Jacobio Debuts on Hong Kong Stock Exchange
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies - ScienceDirect
AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
JAB-3068 - Chemietek
安进KRAS 突变抑制剂AMG 510 国内获批临床-Insight数据库
Small‐Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview - Mitra - 2021 - ChemMedChem - Wiley Online Library
临床招募| JAB-3312免疫+靶向双重作用治疗晚期实体瘤- 知乎
KRAS G12C Inhibitor | Jacobio Pharma
Jacobio Earns $20M AbbVie Milestone | Contract Pharma
美银证券盘点全球SHP2研发现状，称加科思为全球黑马| 会员动态_生物_医药_写意
1: The Shp2 inhibitor, II-B08 | Download Scientific Diagram
Structure of the candidates SHP2 inhibitor. (a) HER222 (P= 1.11 x... | Download Scientific Diagram
Jacobio's Preclinical Results of KRAS G12C Inhibitor in Combination with SHP2 Inhibitor Will be Presented at the ESMO Asia Congress 2022
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies - ScienceDirect
加科思：专注难成药靶点药物研发的新明珠
IJMS | Free Full-Text | Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
Small‐Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview - Mitra - 2021 - ChemMedChem - Wiley Online Library
Strategies to overcome drug resistance using SHP2 inhibitors - ScienceDirect
:%0A%0AJAB-3312%20for%20Solid%20Tumors,%20Adult.png?md=1 "JAB-3312 for Solid Tumors, Adult Clinical Trial 2023 | Power")
JAB-3312 for Solid Tumors, Adult Clinical Trial 2023 | Power
医药魔方
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies - ScienceDirect
医药魔方
安进带火的KRAS 抑制剂JAB-3312 在中国的临床申请获得承办
